Trials / Completed
CompletedNCT05054608
Long Term Outcome in ICU Treated COVID-19: Return to Work
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 13,537 (actual)
- Sponsor
- Uppsala University · Academic / Other
- Sex
- All
- Age
- 18 Years – 63 Years
- Healthy volunteers
- Not accepted
Summary
Return to work (not being on sick leave) within one year after intensive care unit (ICU) admission with Coronavirus disease 2019 (COVID-19) will be assessed. Risk and risk factors for not having returned to work will be compared to patients admitted to hospital and general population controls. The ICU population comprises all Swedish ICU patients with COVID-19 with at least one year of follow up. The hospital admitted cohort comprises four hospital admitted patients with COVID-19 per ICU patient, matched on age, legal gender and region. The general population controls are matched to the ICU patients in a one to four fashion on age, legal gender and region. ICU patients are identified in the Swedish intensive care registry. The hospital admitted patients are identified in the national patient registry and the population controls are identified in the population registry. Data on socioeconomics and income are provided by the Statistics Sweden. Data on comorbidity, medications and death are provided from the National board of health and welfare. Finally, data on sick leave are provided from the Swedish Social Insurance Agency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | Observational study. No intervention. |
Timeline
- Start date
- 2021-10-15
- Primary completion
- 2021-11-15
- Completion
- 2021-11-15
- First posted
- 2021-09-23
- Last updated
- 2022-12-05
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT05054608. Inclusion in this directory is not an endorsement.